Ahead Biocomputing was selected as a winner of the Toshiba OPEN INNOVATION PROGRAM 2021 in the category of business planning with the Simulated Bifurcation Machines (SBM) developed by Toshiba. On September 24th, the members of Ahead Biocomputing's development team made an oral presentation of our achievements on the proposed theme "Formulation of drug discovery solutions using combinational optimization solvers" at the meeting of the program. The program is designed to support companies accelerate their commercialization through collaboration with Toshiba Group, utilizing Toshiba Group's business assets and advanced technologies. This particular work was achieved in collaboration with another start-up company selected in this category, Revorf Co., Ltd.
Revorf Co., Ltd
https://www.revorf.jp/Toshiba Simulated Bifurcation Machine (SBM) | TOSHIBA DIGITAL SOLUTIONS CORPORATION
https://www.global.toshiba/ww/products-solutions/ai-iot/sbm.html
